|
No. of patients (%)
|
18,609 (53.2)
|
16,390 (46.8)
| |
11,409 (50.0)
|
11,409 (50.0)
| |
|
Age
| | |
<.0001
| | |
0.94
|
|
18–49
|
1,678 (9.0)
|
1424 (8.7)
|
935 (8.2)
|
920 (8.1)
|
|
50–64
|
4,628 (24.9)
|
5284 (32.2)
|
2,979 (26.1)
|
3,016 (26.4)
|
|
65–74
|
4,368 (23.5)
|
4419 (27.0)
|
2,957 (25.9)
|
2,956 (25.9)
|
|
75 and more
|
7,935 (42.6)
|
5263 (32.1)
|
4,538 (39.8)
|
4,517 (39.6)
|
|
Distance from cancer reporting facility
| | |
0.06
| | |
0.58
|
|
<50 miles
|
16,909 (92.9)
|
15,015 (93.4)
|
10,630 (93.2)
|
10,651 (93.4)
|
|
≥50 miles
|
1,303 (7.2)
|
1,066 (6.6)
|
779 (6.8)
|
758 (6.6)
|
|
Race/Ethnicity
| | |
<.0001
| | |
0.93
|
|
White
|
15,964 (86.5)
|
13,450 (82.8)
| |
9,785 (85.8)
|
9,770 (85.6)
|
|
Black
|
1,965 (10.6)
|
2,197 (13.5)
| |
1,283 (11.3)
|
1,308 (11.5)
|
|
American Indian, Aleutian, or Eskimo
|
53 (0.3)
|
36 (0.2)
| |
27 (0.2)
|
31 (0.3)
|
|
Asian or Pacific Islander
|
390 (2.1)
|
456 (2.8)
| |
261 (2.3)
|
251 (2.2)
|
|
Other
|
89 (0.5)
|
100 (0.6)
| |
53 (0.5)
|
49 (0.4)
|
|
Facility Type
| | |
0.02
| | |
0.90
|
|
Community cancer program
|
2,715 (14.6)
|
2,239 (13.7)
|
1,565 (13.7)
|
1,588 (13.9)
|
|
Comprehensive community cancer center
|
11,044 (59.4)
|
9,700 (59.2)
|
6,815 (59.7)
|
6,804 (59.6)
|
|
Academic research program
|
4,825 (25.9)
|
4,432 (27.0)
|
3,029 (26.6)
|
3,017 (26.4)
|
|
Other specified types of cancer program
|
25 (0.1)
|
19 (0.1)
| | |
|
Facility Location
| | |
<.0001
| | |
0.99
|
|
New England
|
1,335 (7.2)
|
886 (5.4)
|
678 (5.9)
|
692 (6.1)
|
|
Mid Atlantic
|
2,971 (16.0)
|
2,402 (14.7)
|
1,814 (15.9)
|
1,809 (15.9)
|
|
South Atlantic
|
3,835 (20.6)
|
3,715 (22.7)
|
2,352 (20.6)
|
2,391 (21.0)
|
|
East North Central
|
3,580 (19.2)
|
3,127 (19.1)
|
2,174 (19.1)
|
2,201 (19.3)
|
|
East South Central
|
1,162 (6.2)
|
1,186 (7.2)
|
788 (6.9)
|
786 (6.9)
|
|
West North Central
|
1,555 (8.4)
|
1,333 (8.1)
|
1,035 (9.1)
|
1,002 (8.8)
|
|
West South Central
|
1,487 (8.0)
|
1,391 (8.5)
|
942 (8.3)
|
938 (8.2)
|
|
Mountain
|
779 (4.2)
|
678 (4.1)
|
440 (3.9)
|
438 (3.8)
|
|
Pacific
|
1,905 (10.2)
|
1,672 (10.2)
|
1,186 (10.4)
|
1,152 (10.1)
|
|
Urban/Rural Location
| | |
0.05
| | |
0.96
|
|
Metro ≥1 million
|
9,488 (53.0)
|
8,380 (53.1)
|
6,039 (52.9)
|
6,028 (52.8)
|
|
Metro 250 k to 1 million
|
3,863 (21.6)
|
3,556 (22.5)
|
2,539 (22.3)
|
2,554 (22.4)
|
|
Urban <250 k
|
1,766 (9.9)
|
1,516 (9.6)
|
1,104 (9.7)
|
1,112 (9.8)
|
|
Urban ≥ 20 k adjacent metro
|
731 (4.1)
|
657 (4.2)
|
460 (4.0)
|
476 (4.2)
|
|
Urban ≥ 20 k not adjacent metro
|
262 (1.5)
|
221 (1.4)
|
182 (1.6)
|
175 (1.5)
|
|
Urban <20 k adjacent metro
|
957 (5.4)
|
751 (4.8)
|
577 (5.1)
|
572 (5.0)
|
|
Urban <20 k not adjacent metro
|
454 (2.5)
|
387 (2.5)
|
286 (2.5)
|
258 (2.3)
|
|
Rural <2500 adjacent metro
|
164 (0.9)
|
169 (1.1)
|
108 (1.0)
|
109 (1.0)
|
|
Rural <2500 not adjacent metro
|
212 (1.2)
|
154 (1.0)
|
114 (1.0)
|
125 (1.1)
|
|
Comorbidities
| | |
<.0001
| | |
0.61
|
|
0
|
12,872 (69.2)
|
11,665 (71.2)
|
7,905 (69.3)
|
7,962 (69.8)
|
|
1
|
4,185 (22.5)
|
3,537 (21.6)
|
2,576 (22.6)
|
2,513 (22.0)
|
|
2
|
1,552 (8.3)
|
1,188 (7.3)
|
928 (8.1)
|
934 (8.2)
|
|
Primary Site
| | |
<.0001
| | |
0.99
|
|
Cecum
|
4,917 (26.4)
|
3,941 (24.1)
|
3,077 (27.0)
|
3,077 (27.0)
|
|
Ascending Colon
|
2,876 (15.5)
|
3,140 (19.2)
|
1,969 (17.3)
|
1,992 (17.5)
|
|
Hepatic Flexure
|
748 (4.0)
|
608 (3.7)
|
473 (4.2)
|
461 (4.0)
|
|
Transverse Colon
|
2,061 (11.1)
|
1,154 (7.0)
|
1,031 (9.0)
|
991 (8.7)
|
|
Splenic Flexure
|
786 (4.2)
|
366 (2.2)
|
312 (2.7)
|
327 (2.9)
|
|
Descending Colon
|
1,161 (6.2)
|
960 (5.9)
|
705 (6.2)
|
706 (6.2)
|
|
Sigmoid Colon
|
5,324 (28.6)
|
5,756 (35.1)
|
3,524 (30.9)
|
3,535 (31.0)
|
|
Overlapping Lesions
|
369 (2.0)
|
140 (0.9)
|
120 (1.1)
|
121 (1.1)
|
|
Not Otherwise Specified
|
367 (2.0)
|
325 (2.0)
|
198 (1.7)
|
199 (1.7)
|
|
Grade
| | |
<.0001
| | |
0.87
|
|
Well differentiated
|
1,506 (8.4)
|
1,779 (11.4)
|
1,087 (9.5)
|
1,084 (9.5)
|
|
Moderately differentiated
|
11,868 (66.0)
|
11,226 (71.9)
|
8,007 (70.2)
|
8,049 (70.6)
|
|
Poorly differentiated
|
4,004 (22.3)
|
2,381 (15.3)
|
2,084 (18.3)
|
2,059 (18.1)
|
|
Undifferentiated, anaplastic
|
611 (3.4)
|
230 (1.5)
|
231 (2.0)
|
217 (1.9)
|
|
Surgical Margins
| | |
<.0001
| | |
0.87
|
|
No residual tumor
|
14992 (82.6)
|
16,012 (98.8)
|
11,243 (98.6)
|
11,246 (98.6)
|
|
With Residual tumor
|
3156 (17.4)
|
190 (1.2)
|
166 (1.5)
|
163 (1.4)
|
|
Regional Lymph Nodes Examined
| | |
<.0001
| | |
<.0001
|
|
0–11
|
4,399 (23.8)
|
4,867 (29.9)
|
2,422 (21.3)
|
3,298 (29.0)
|
|
12–90
|
14,101 (76.2)
|
11,434 (70.1)
|
8,944 (78.7)
|
8,078 (71.0)
|
|
Chemotherapy
| | |
<.0001
| | |
<.0001
|
|
None
|
10,423 (58.7)
|
4,807 (30.5)
|
6,362 (58.4)
|
3,659 (33.3)
|
|
Yes
|
7,335 (41.3)
|
10,975 (69.5)
|
4,525 (41.6)
|
7,327 (66.7)
|
